Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1

Conditions

Carcinoma, Non-Small-Cell Lung 27Prostatic Neoplasms 26Brain Neoplasms 23Lung Neoplasms 17Neoplasm Metastasis 15Breast Neoplasms 12Melanoma 9Carcinoma, Renal Cell 8Pancreatic Neoplasms 6Colorectal Neoplasms 6Carcinoma, Hepatocellular 4Urinary Bladder Neoplasms 3Neoplasms 3NSCLC 3Meningioma 3Gastrointestinal Neoplasms 3Unresectable Locally Recurrent Rectal Cancer 2Thyroid Neoplasms 2Squamous Cell Carcinoma of Head and Neck 2Spinal Cord Compression 2Small Cell Lung Carcinoma 2Sarcoma 2Hematologic Neoplasms 2Head and Neck Neoplasms 2Epidural Neoplasms 2Carcinoma, Transitional Cell 2Adenocarcinoma 2Uveal Melanoma 1Uterine Cervical Neoplasms 1Urogenital Neoplasms 1

Interventions

Carboplatin 3Pemetrexed 2Cisplatin 2selpercatinib 1repotrectinib 1pembrolizumab 1durvalumab 1cemiplimab 1capmatinib 1aflutinib 1Toll-Like Receptor 1 1Radiosurgery 1Platinum Compounds 1Paclitaxel 1Gemcitabine 1Docetaxel 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Bronchial Neoplasms × Radiosurgery × 90 days × Clear all
NCT06623656 2026-04-21

Preoperative Radioimmunotherapy Versus Chemoimmunotherapy in NSCLC

Weill Medical College of Cornell University

Phase 2 Recruiting
112 enrolled
Thoracic

Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, Lung Neoplasms, Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡